The Ensign Group (ENSG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Operates 395 facilities with over 44,000 beds/units and 57,000+ employees across 17 states, focusing on post-acute care, skilled nursing, senior living, and ancillary services.
Achieved record year and quarter in key financial and operational metrics, with Q1 2026 revenue up 18.4% to $1.39B, driven by higher occupancy, rate increases, and acquisitions.
Net income attributable to shareholders rose 24.2% to $99.7M, with GAAP diluted EPS up 21.9% to $1.67 and adjusted EPS up 21.7% to $1.85.
Local leadership and cluster models, along with a patient-focused culture, drive superior clinical outcomes and operational rigor, supporting organic and acquisition-led growth.
Same-store and transitioning occupancy reached record highs at 84.3% and 85.1%, with significant increases in skilled days and Medicare/Managed Care revenue.
Financial highlights
Q1 2026 consolidated revenue was $1.39B (+18.4% YoY); service revenue $1.38B; rental revenue $36.1M (+27.1% YoY); GAAP net income $99.7M (+24.2% YoY); adjusted net income $110.2M (+23.9% YoY).
Adjusted EBITDA for Q1 2026 was $171.2M; adjusted EBITDAR $236.7M.
Cash and cash equivalents at quarter-end were $539.5M; cash flow from operations was $100.2M.
Lease-adjusted net debt-to-EBITDA/EBITDAR improved to 1.73x at Q1 2026.
Quarterly cash dividend of $0.065 per share paid for the 23rd consecutive year.
Outlook and guidance
2026 annual revenue guidance is $5.81B–$5.86B; diluted adjusted EPS guidance is $7.48–$7.62, representing a 15% increase over 2025 and 37% over 2024.
Guidance incorporates expected acquisitions, reimbursement rates, normalized insurance costs, and a 25% tax rate.
Existing cash, investments, and projected cash flows are expected to support operations and expansion.
Latest events from The Ensign Group
- Director elections, auditor ratification, and say-on-pay up for vote at annual meeting.ENSG
Proxy filing2 Apr 2026 - 2025 saw record growth, enhanced governance, and performance-driven executive compensation.ENSG
Proxy filing2 Apr 2026 - Strong growth, robust acquisitions, and proactive regulatory management drive future upside.ENSG
Oppenheimer 36th Annual Healthcare MedTech & Services Conference19 Mar 2026 - Record revenue, earnings, and occupancy drive double-digit FY26 growth outlook.ENSG
Q4 20256 Feb 2026 - Q3 revenue up 15%, net income up 22.8%, and guidance raised amid record occupancy and expansion.ENSG
Q3 20245 Feb 2026 - Record Q2 growth, raised 2024 guidance, and continued disciplined expansion.ENSG
Q2 20242 Feb 2026 - Growth is fueled by leadership, local empowerment, and disciplined acquisitions amid a stable regulatory outlook.ENSG
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Record 2024 results and strong 2025 outlook driven by growth, acquisitions, and financial strength.ENSG
Q4 202426 Dec 2025 - Q1 2025 revenue up 16.1%, net income up 16.6%, and 2025 guidance raised after record growth.ENSG
Q1 202522 Dec 2025